COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    econs
Previous Study | Return to List | Next Study

Use of ACTIMMUNE in Patients With ADO2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02584608
Recruitment Status : Completed
First Posted : October 22, 2015
Last Update Posted : November 14, 2019
Horizon Pharma Ireland, Ltd., Dublin Ireland
Information provided by (Responsible Party):
Michael Econs, Indiana University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 12, 2019
Actual Study Completion Date : November 12, 2019